External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home AATS 2024
Roche and Genentech at

AATS 2024

April 27 - April 30
Toronto, Canada
events.aats.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
12:00 PM
Duration 12mins Metro Toronto Convention Center, Exhibit Hall FG
Disease characteristics and treatment outcomes in patients with resected early-stage ALK+ NSCLC from ALINA, a phase III randomized trial of adjuvant alectinib vs. chemotherapy
Yi-Long Wu, Benjamin J. Solomon, Jin Seok Ahn, Fabrice Barlesi, Makoto Nishio, Dae Ho Lee, Jong-Seok Lee, Wenzhao Zhong, Hidehito Horinouchi, Weimin Mao, Maximilian Hochmair, Filippo de Marinis, Maria Rita Migliorino, Igor Bondarenko, Tingting Xu, Ilze Bara, Wei Yu, Celina Ngiam, Patricia Petric, Rafal Dziadziuszko
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.